dc.contributor.author |
El-Khazragy, Nashwa |
|
dc.contributor.author |
Mohammed, Hayam Fathy |
|
dc.contributor.author |
Yassin, Mohamed |
|
dc.contributor.author |
Elghoneimy, K.K. |
|
dc.contributor.author |
Bayoumy, Walid |
|
dc.contributor.author |
Hewety, Amr |
|
dc.contributor.author |
EL Magdoub, Hekmat M. |
|
dc.contributor.author |
Elayat, Wael |
|
dc.contributor.author |
Zaki, Walid |
|
dc.contributor.author |
Safwat, Gehan |
|
dc.contributor.author |
Mosa, Mai |
|
dc.contributor.author |
Zedan, Khouloud |
|
dc.contributor.author |
Salem, Salema |
|
dc.contributor.author |
Bannunah, Azzah M. |
|
dc.contributor.author |
Mansy, Azza |
|
dc.date.accessioned |
2020-08-12T12:36:35Z |
|
dc.date.available |
2020-08-12T12:36:35Z |
|
dc.date.issued |
2020-08 |
|
dc.identifier.other |
https://doi.org/10.1016/j.ygeno.2020.08.005 |
|
dc.identifier.uri |
https://t.ly/9kLR |
|
dc.description.abstract |
Objectives: The current study aimed to investigate the potentiality of three lncRNAs
“Plasmacytoma variant translocation 1(lnc-PVT1), Taurine upregulated gene type 1(lnc-
TUG1) and Maternally expressed gene 3 (lnc-MEG-3)”, to predict Cisplatin resistance in
ovarian cancer (OC), in addition, to access their prognostic significance.
Methods: The expression level of lncRNAs were measured in 100 formalin-fixed paraffin-
embedded tissue (FFET) samples of OC patients who were treated by Cisplatin-based
chemotherapy using qPCR.Results: The results showed that lnc_PVT1 was significantly higher by 2.3 folds in Cisplatin
resistant tissues, while, lnc-TUG1 and lnc-MEG3 were downregulated by 1.2 and 3 folds,
respectively. In addition, the three lncRNAs exhibited high sensitivity and specificity in
predicting chemo-resistance and they were negatively associated with OS and progression-
free survival (p<0.001).
Conclusion: The lnc-PVT1, lnc-TUG1, and lnc-MEG3 transcriptome signatures could be
used for predicting resistance to Cisplatin in OC patients. |
en_US |
dc.language.iso |
en_US |
en_US |
dc.publisher |
Elsevier Inc.Mansy |
en_US |
dc.relation.ispartofseries |
Genomics;S0888-7543(20)30846-6 |
|
dc.subject |
lnc- MEG3. |
en_US |
dc.subject |
lnc-TUG1 |
en_US |
dc.subject |
lnc-PVT1 |
en_US |
dc.subject |
Cisplatin resistance |
en_US |
dc.subject |
Long non-coding RNA |
en_US |
dc.subject |
Ovarian cancer |
en_US |
dc.title |
Tissue-based long non-coding RNAs “PVT1, TUG1 and MEG3” signature predicts Cisplatin resistance in ovarian Cancer |
en_US |
dc.type |
Article |
en_US |
dc.identifier.doi |
https://doi.org/10.1016/j.ygeno.2020.08.005 |
|
dc.Affiliation |
October University for modern sciences and Arts (MSA) |
|